Splice-variant- and stage-specific RNA editing of the drosophila GABA receptor modulates agonist potency

59Citations
Citations of this article
72Readers
Mendeley users who have this article in their library.

Abstract

The molecular diversity of many gene products functioning in the nervous system is enhanced by alternative splicing and adenosine-to-inosine editing of pre-mRNA. Using RDL, a Drosophila melanogaster GABA-gated ion channel, we examined the functional impact of RNA editing at several sites along with alternative splicing of more than one exon. We show that alternative splicing and RNA editing have a combined influence on the potency of the neurotransmitter GABA, and the editing isoforms detected in vivo span the entire functional range of potencies seen for all possible edit variants expressed in Xenopus laevis oocytes. The extent of RNA editing is developmentally regulated and can also be linked to the choice of alternative exons. These results provide insights into how the rich diversity of signaling necessary for complex brain function can be achieved by relatively few genes. Copyright © 2009 Society for Neuroscience.

Cite

CITATION STYLE

APA

Jones, A. K., Buckingham, S. D., Papadaki, M., Yokota, M., Sattelle, B. M., Matsuda, K., & Sattelle, D. B. (2009). Splice-variant- and stage-specific RNA editing of the drosophila GABA receptor modulates agonist potency. Journal of Neuroscience, 29(13), 4287–4292. https://doi.org/10.1523/JNEUROSCI.5251-08.2009

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free